| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | GSK461364 | CTRPv2 | pan-cancer | AAC | -0.091 | 0.006 |
| mRNA | CHIR-99021 | GDSC1000 | pan-cancer | AAC | 0.091 | 0.006 |
| mRNA | parbendazole | CTRPv2 | pan-cancer | AAC | -0.087 | 0.007 |
| mRNA | BRD-K49290616 | CTRPv2 | pan-cancer | AAC | 0.2 | 0.008 |
| mRNA | MK 1775 | CTRPv2 | pan-cancer | AAC | -0.092 | 0.008 |
| mRNA | paclitaxel | CTRPv2 | pan-cancer | AAC | -0.09 | 0.009 |
| mRNA | narciclasine | CTRPv2 | pan-cancer | AAC | -0.088 | 0.009 |
| mRNA | ZG-10 | GDSC1000 | pan-cancer | AAC | 0.12 | 0.01 |
| mRNA | BRD-K33514849 | CTRPv2 | pan-cancer | AAC | 0.33 | 0.01 |
| mRNA | SR-II-138A | CTRPv2 | pan-cancer | AAC | -0.083 | 0.01 |